Your fact-checks will appear here
Company in Seattle, United States
From 2020–2025 the most clearly documented tinnitus device to receive U.S. FDA clearance is Neuromod Devices’ Lenire, which earned De Novo approval in March 2023 based on the TENT‑A3 pivotal trial and...
No explicit, formal endorsements or dedicated recommendations for repurposed antiparasitic drugs appear in the recent guideline summaries and updates from the National Comprehensive Cancer Network (NC...
There is no evidence in the provided reporting that any regulator‑approved supplement can modify the biological progression of frontotemporal dementia (FTD); multiple clinical reviews and advocacy gro...
Yes — the FDA has approved tirzepatide (branded as Zepbound) for chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight‑related conditi...